[1]
|
Christopoulos, G., Wyman, R.M., Alaswad, K., et al. (2015) Clinical Utility of the Japan-Chronic Total Occlusion Score in Coronary Chronic Total Occlusion Interventions: Results from a Multicenter Registry. Circulation: Cardiovascular Interventions, 8, e002171. https://doi.org/10.1161/CIRCINTERVENTIONS.114.002171
|
[2]
|
Morino, Y., Kimura, T., Hayashi, Y., et al. (2010) In-Hospital Outcomes of Contemporary Percutaneous Coronary Intervention in Patients with Chronic Total Occlusion. JACC: Cardiovascular Interventions, 3, 143-151.
https://doi.org/10.1016/j.jcin.2009.10.029
|
[3]
|
Ybarra, L.F., Rinfret, S., Brilakis, E.S., et al. (2021) Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-Arc Consensus Recom-mendations. Circulation, 143, 479-500.
https://doi.org/10.1161/CIRCULATIONAHA.120.046754
|
[4]
|
邢浩然, 王锐, 张东凤, 贺毅, 宋现涛. 冠状动脉慢性完全闭塞病变介入治疗评分系统研究现状[J]. 中国循证心血管医学杂志, 2021, 13(11): 1398-400+403.
|
[5]
|
Christopoulos, G., Kandzari, D.E., Yeh, R.W., et al. (2016) Development and Validation of a Nov-el Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions. JACC: Cardiovascular Interventions, 9, 1-9. https://doi.org/10.1016/j.jcin.2015.09.022
|
[6]
|
Koelbl, C.O., Nedel-jkovic, Z.S. and Jacobs, A.K. (2018) Coronary Chronic Total Occlusion (CTO): A Review. Reviews in Cardiovascular Medicine, 19, 33-39. https://doi.org/10.31083/j.rcm.2018.01.896
|
[7]
|
魏恒争. 冠脉慢性完全闭塞病变闭塞支数对心肌功能及心室重构的影响[J]. 承德医学院学报, 2020, 37(1): 15-18.
|
[8]
|
Xiao, L., Jia, Y., Wang, X., et al. (2019) The Impact of Preoperative Fibrinogen-Albumin Ratio on Mortality in Patients with Acute St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Clinica Chimica Acta, 493, 8-13. https://doi.org/10.1016/j.cca.2019.02.018
|
[9]
|
Fang, L., Yan, F.H., Liu, C., et al. (2021) Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer. Cancer Re-search and Treatment, 53, 131-139.
https://doi.org/10.4143/crt.2020.330
|
[10]
|
Ozcan Cetin, E.H., Könte, H.C. and Temizhan, A. (2019) Blood Viscosi-ty Should Not Be Overlooked When Evaluating the Fibrinogen to Albumin Ratio. Angiology, 70, 465-466. https://doi.org/10.1177/0003319718822244
|
[11]
|
Li, M., Tang, C., Luo, E., et al. (2020) Relation of Fibrino-gen-to-Albumin Ratio to Severity of Coronary Artery Disease and Long-Term Prognosis in Patients with Non-St Eleva-tion Acute Coronary Syndrome. BioMed Research International, 2020, Article ID: 1860268. https://doi.org/10.1155/2020/1860268
|
[12]
|
Erdoğan, G., Arslan, U., Yenercağ, M., et al. (2021) Relationship be-tween the Fibrinogen-to-Albumin Ratio and Syntax Score in Patients with Non-St-Elevation Myocardial Infarction. Re-vista de investigacion clinica, 73, 182-189.
https://doi.org/10.24875/RIC.20000534
|
[13]
|
Zhao, Y., Yang, J., Ji, Y., Wang, S., et al. (2019) Usefulness of Fi-brinogen-to-Albumin Ratio to Predict No-Reflow and Short-Term Prognosis in Patients with St-Segment Elevation My-ocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Heart and Vessels, 34, 1600-1607. https://doi.org/10.1007/s00380-019-01399-w
|
[14]
|
Cetin, M., Erdogan, T., Kiris, T., et al. (2020) Predictive Value of Fibrinogen-to-Albumin Ratio in Acute Coronary Syndrome. Herz, 45, 145-151. https://doi.org/10.1007/s00059-019-4840-5
|
[15]
|
Bryer, E., Stein, E. and Goldberg, S. (2020) Multivessel Coronary Artery Disease: The Limitations of a “One-Size- Fits-All” Approach. Mayo Clinic Proceedings Innovations, Quality & Outcomes, 4, 638-641.
https://doi.org/10.1016/j.mayocpiqo.2020.07.014
|
[16]
|
Gul, F. and Parekh, A. (2022) Multivessel Disease. In: Statpearls. Statpearls Publishing, Treasure Island.
|
[17]
|
赵一品, 汤建民, 季莹莹, 王丰云, 杨雁华, 王顺利. 非St段抬高型急性冠脉综合征患者血清纤维蛋白原/白蛋白与冠脉病变程度的关系[J]. 山东医药, 2018, 58(33): 9-12.
|
[18]
|
Fox, K.A., Dabbous, O.H., Goldberg, R.J., et al. (2006) Prediction of Risk of Death and Myocardial Infarc-tion in the Six Months after Presentation with Acute Coronary Syndrome: Prospective Multinational Observational Study (Grace). BMJ, 333, 1091-1094. https://doi.org/10.1136/bmj.38985.646481.55
|
[19]
|
熊国均, 黄楷森, 欧荣华, 陈检, 雷宇, 胡丽君. 纤维蛋白原与白蛋白比值对多支血管病变性急性心肌梗死患者Pci术后远期预后的预测价值[J]. 疑难病杂志, 2019, 18(12): 1212-1217.
|
[20]
|
Chen, T., Sun, J.L. and Zhang, J. (2020) The Relationship between Fibrinogen-to-Albumin Ratio and Instent Restenosis in Patients with Coronary Artery Disease Undergoing Drug-Eluting Stenting. Coronary Artery Disease, 31, 586-589.
https://doi.org/10.1097/MCA.0000000000000890
|
[21]
|
Freilich, M., Arredondo, A., Zonnoor, S.L., et al. (2022) Elevated Serum Uric Acid and Cardiovascular Disease: A Review and Potential Therapeutic Interventions. Cureus, 14, e23582. https://doi.org/10.7759/cureus.23582
|
[22]
|
Saito, Y., Mori, N., Murase, T., et al. (2021) Greater Coronary Lipid Core Plaque Assessed by Near-Infrared Spectroscopy Intravascular Ultrasound in Patients with Elevated Xanthine Oxidoreductase: A Mechanistic Insight. Heart and Vessels, 36, 597-604. https://doi.org/10.1007/s00380-020-01730-w
|
[23]
|
Duran, M., Ornek, E., Murat, S.N., et al. (2012) High Levels of Serum Uric Acid Impair Development of Coronary Collaterals in Patients with Acute Coronary Syndrome. Angiology, 63, 472-475.
https://doi.org/10.1177/0003319711422433
|
[24]
|
Hsu, P.C., Su, H.M. and Lin, T.H. (2013) Association between Coronary Collaterals and Serum Uric Acid Level in Chinese Population with Acute Coronary Syndrome. Angiology, 64, 323-324.
https://doi.org/10.1177/0003319712463263
|
[25]
|
Koza, Y. (2014) Uric Acid and Coronary Collateral Circulation: To Be or Not to Be? Angiology, 65, 560-562.
https://doi.org/10.1177/0003319713506960
|
[26]
|
Uysal, O.K., Sahin, D.Y., Duran, M., et al. (2014) Association between Uric Acid and Coronary Collateral Circulation in Patients with Stable Coronary Artery Disease. Angiology, 65, 227-231. https://doi.org/10.1177/0003319713500706
|
[27]
|
Sachdeva, R., Agrawal, M., Flynn, S.E., et al. (2014) The Myocardium Supplied by a Chronic Total Occlusion Is a Persistently Ischemic Zone. Catheterization and Cardio-vascular Interventions, 83, 9-16.
https://doi.org/10.1002/ccd.25001
|